Making progress against cancer in Europe in 2008

Albreht, Tit; McKee, Martin; Alexe, Delia-Marina; Coleman, Michel P; Martín-Moreno, José M.

doi:10.1016/j.ejca.2008.02.015

Cited by 51 publications

(32 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…), a reorganisation following such a path requires a definition of MDT boundaries and scope of practice, promoting adherence to the coordination mechanisms put in place, providing administrative support, and promoting team roles and distributed leadership compatible with traditional hierarchies. Policymakers and hospital managers may greatly contribute to the effectiveness and stability of this system by articulating these operating conditions, stimulating clinical accountability for the decisions made and ensuring liability on patients' clinical pathway, including in communication with them [71].…”

Section: Discussionmentioning

confidence: 99%

Is it worth reorganising cancer services on the basis of multidisciplinary teams (MDTs)? A systematic review of the objectives and organisation of MDTs and their impact on patient outcomes

et al. 2015

View full text Add to dashboard Cite

a b s t r a c tMultidisciplinary teams (MDTs) are considered the gold standard of cancer care in many healthcare systems, but a clear definition of their format, scope of practice and operational criteria is still lacking. The aims of this review were to assess the impact of MDTs on patient outcomes in cancer care and identify their objectives, organisation and ability to engage patients in their care. We conducted a systematic review of the literature in the Medline database. Fifty-one peer-reviewed papers were selected from November 2005 to June 2012. MDTs resulted in better clinical and process outcomes for cancer patients, with evidence of improved survival among colorectal, head and neck, breast, oesophageal and lung cancer patients in the study period. Also, it was observed that MDTs have been associated with changes in clinical diagnostic and treatment decision-making with respect to urological, pancreatic, gastro-oesophageal, breast, melanoma, bladder, colorectal, prostate, head and neck and gynaecological cancer. Evidence is consistent in showing positive consequences for patients' management in multiple dimensions, which should encourage the development of structured multidisciplinary care, minimum standards and exchange of best practices.

show abstract

Section: Discussionmentioning

confidence: 99%

Is it worth reorganising cancer services on the basis of multidisciplinary teams (MDTs)? A systematic review of the objectives and organisation of MDTs and their impact on patient outcomes

et al. 2015

View full text Add to dashboard Cite

show abstract

“…Cancer is one of the main causes of death in western countries, with 1 in 4 deaths in the European Union (EU) attributable to cancer, though there are large differences between countries in terms of both incidence and survival [5]. Cancer is the second leading cause of death in the Spanish population (accounting for 26% of all deaths), with nearly 100,000 deaths in 2007 according to the Instituto Nacional de Estadística [6,7].…”

Section: Cancer Epidemiology In Spainmentioning

confidence: 99%

The White Book of Radiation Oncology in Spain

et al. 2011

View full text Add to dashboard Cite

The White Book of Radiation Oncology provides a comprehensive overview of the current state of the speciality of radiation oncology in Spain and is intended to be used as a reference for physicians, health care administrators and hospital managers. The present paper summarises the most relevant aspects of the book's 13 chapters in order to bring the message to a wider audience. Among the topics discussed are the epidemiology of cancer in Spain, the role of the radiation oncologist in cancer care, human and material resource needs, new technologies, training of specialists, clinical and cost management, clinical practice, quality control, radiological protection, ethics, relevant legislation, research & development, the history of radiation oncology in Spain and the origins of the Spanish Society of Radiation Oncology (SEOR).

show abstract

“…In fact, cancer is a huge and growing contributor to the burden of disease and premature death worldwide: every year, more than 12 000 000 new cancer cases are diagnosed (25% in Europe) and more than 7 500 000 people die due to cancer-related causes (23% in Europe) [1] ; about 25% of all deaths in the EU are attributable to cancer, and in the age range 45-64 years the percentage increases to almost 50% [2] . In addition, population growth and ageing are expected to further increase these numbers.…”

Section: Academic Strategy and Goalsmentioning

confidence: 99%

Theranostic applications: Non-ionizing cellular and molecular imaging through innovative nanosystems for early diagnosis and therapy

Casciaro¹

2011

WJR

View full text Add to dashboard Cite

Modern medicine is expanding the possibilities of receiving "personalized" diagnosis and therapies, providing minimal invasiveness, technological solutions based on non-ionizing radiation, early detection of pathologies with the main objectives of being operator independent and with low cost to society. Our research activities aim to strongly contribute to these trends by improving the capabilities of current diagnostic imaging systems, which are of key importance in possibly providing both optimal diagnosis and therapies to patients. In medical diagnostics, cellular imaging aims to develop new methods and technologies for the detection of specific metabolic processes in living organisms, in order to accurately identify and discriminate normal from pathological tissues. In fact, most diseases have a "molecular basis" that detected through these new diagnostic methodologies can provide enormous benefits to medicine. Nowadays, this possibility is mainly related to the use of �ositron Emission Tomography, with an exposure to ionizing radiation for patients and operators and with extremely high medical diagnostics costs. The future possible development of non-ionizing cellular imaging based on techniques such as Nuclear Magnetic Resonance or Ultrasound, would represent an important step towards modern and personalized therapies. During the last decade, the field of nanotechnology has made important progress and a wide range of organic and inorganic nanomaterials are now available with an incredible number of further combinations with other compounds for cellular targeting. The availability of these new advanced nanosystems allows new scenarios in diagnostic methodologies which are potentially capable of providing morphological and functional information together with metabolic and cellular indications.

show abstract

Making progress against cancer in Europe in 2008

Cited by 51 publications

References 8 publications

Is it worth reorganising cancer services on the basis of multidisciplinary teams (MDTs)? A systematic review of the objectives and organisation of MDTs and their impact on patient outcomes

Is it worth reorganising cancer services on the basis of multidisciplinary teams (MDTs)? A systematic review of the objectives and organisation of MDTs and their impact on patient outcomes

The White Book of Radiation Oncology in Spain

Theranostic applications: Non-ionizing cellular and molecular imaging through innovative nanosystems for early diagnosis and therapy

Contact Info

Product

Resources

About